nodes	percent_of_prediction	percent_of_DWPC	metapath
Lamivudine—ABCC1—Vandetanib—thyroid cancer	0.119	0.176	CbGbCtD
Lamivudine—ABCC4—Sorafenib—thyroid cancer	0.089	0.132	CbGbCtD
Lamivudine—ABCC1—Epirubicin—thyroid cancer	0.0817	0.121	CbGbCtD
Lamivudine—ABCG2—Vandetanib—thyroid cancer	0.0794	0.118	CbGbCtD
Lamivudine—ABCC3—Doxorubicin—thyroid cancer	0.0707	0.105	CbGbCtD
Lamivudine—ABCC2—Sorafenib—thyroid cancer	0.0529	0.0787	CbGbCtD
Lamivudine—ABCG2—Sorafenib—thyroid cancer	0.0479	0.0711	CbGbCtD
Lamivudine—ABCC1—Doxorubicin—thyroid cancer	0.0434	0.0645	CbGbCtD
Lamivudine—ABCC2—Doxorubicin—thyroid cancer	0.0321	0.0477	CbGbCtD
Lamivudine—ABCG2—Doxorubicin—thyroid cancer	0.029	0.0432	CbGbCtD
Lamivudine—ABCB1—Sorafenib—thyroid cancer	0.0173	0.0257	CbGbCtD
Lamivudine—ABCB1—Doxorubicin—thyroid cancer	0.0105	0.0156	CbGbCtD
Lamivudine—NME1—neck—thyroid cancer	0.00495	0.0697	CbGeAlD
Lamivudine—PCYT2—head—thyroid cancer	0.00459	0.0647	CbGeAlD
Lamivudine—PGK1—head—thyroid cancer	0.00394	0.0555	CbGeAlD
Lamivudine—NT5C—thyroid gland—thyroid cancer	0.00375	0.0529	CbGeAlD
Lamivudine—NME1—Bosutinib—Vandetanib—thyroid cancer	0.00364	0.545	CbGdCrCtD
Lamivudine—NME1-NME2—head—thyroid cancer	0.00359	0.0506	CbGeAlD
Lamivudine—NT5C—head—thyroid cancer	0.00333	0.0469	CbGeAlD
Lamivudine—PCYT1A—head—thyroid cancer	0.00312	0.044	CbGeAlD
Lamivudine—NME1-NME2—lymph node—thyroid cancer	0.00251	0.0354	CbGeAlD
Lamivudine—NME1—thyroid gland—thyroid cancer	0.00235	0.0332	CbGeAlD
Lamivudine—NT5C—lymph node—thyroid cancer	0.00233	0.0328	CbGeAlD
Lamivudine—CMPK1—thyroid gland—thyroid cancer	0.00227	0.032	CbGeAlD
Lamivudine—NME2—thyroid gland—thyroid cancer	0.00222	0.0312	CbGeAlD
Lamivudine—NME1—head—thyroid cancer	0.00209	0.0294	CbGeAlD
Lamivudine—CMPK1—head—thyroid cancer	0.00201	0.0284	CbGeAlD
Lamivudine—NME2—head—thyroid cancer	0.00197	0.0277	CbGeAlD
Lamivudine—DCK—saliva-secreting gland—thyroid cancer	0.00185	0.0261	CbGeAlD
Lamivudine—SLC22A3—saliva-secreting gland—thyroid cancer	0.00151	0.0213	CbGeAlD
Lamivudine—NME1—lymph node—thyroid cancer	0.00146	0.0206	CbGeAlD
Lamivudine—DCK—trachea—thyroid cancer	0.00143	0.0201	CbGeAlD
Lamivudine—CMPK1—lymph node—thyroid cancer	0.00141	0.0199	CbGeAlD
Lamivudine—NME2—lymph node—thyroid cancer	0.00138	0.0194	CbGeAlD
Lamivudine—NME1—Afatinib—Vandetanib—thyroid cancer	0.00137	0.206	CbGdCrCtD
Lamivudine—NME1—Gefitinib—Vandetanib—thyroid cancer	0.0012	0.18	CbGdCrCtD
Lamivudine—DCK—thyroid gland—thyroid cancer	0.00113	0.0159	CbGeAlD
Lamivudine—ABCC3—thyroid gland—thyroid cancer	0.00108	0.0152	CbGeAlD
Lamivudine—ABCG2—saliva-secreting gland—thyroid cancer	0.00103	0.0146	CbGeAlD
Lamivudine—DCK—head—thyroid cancer	0.001	0.0141	CbGeAlD
Lamivudine—ABCC1—trachea—thyroid cancer	0.000963	0.0136	CbGeAlD
Lamivudine—ABCC3—head—thyroid cancer	0.00096	0.0135	CbGeAlD
Lamivudine—SLC22A3—thyroid gland—thyroid cancer	0.000921	0.013	CbGeAlD
Lamivudine—ABCC4—thyroid gland—thyroid cancer	0.000893	0.0126	CbGeAlD
Lamivudine—SLC22A1—head—thyroid cancer	0.000855	0.012	CbGeAlD
Lamivudine—SLC22A3—head—thyroid cancer	0.000817	0.0115	CbGeAlD
Lamivudine—ABCC4—head—thyroid cancer	0.000792	0.0112	CbGeAlD
Lamivudine—ABCC1—thyroid gland—thyroid cancer	0.000762	0.0107	CbGeAlD
Lamivudine—DCK—lymph node—thyroid cancer	0.000702	0.00989	CbGeAlD
Lamivudine—ABCC3—lymph node—thyroid cancer	0.000672	0.00947	CbGeAlD
Lamivudine—ABCG2—thyroid gland—thyroid cancer	0.00063	0.00888	CbGeAlD
Lamivudine—SLC22A3—lymph node—thyroid cancer	0.000572	0.00806	CbGeAlD
Lamivudine—ABCC4—lymph node—thyroid cancer	0.000555	0.00781	CbGeAlD
Lamivudine—ABCC2—lymph node—thyroid cancer	0.000537	0.00756	CbGeAlD
Lamivudine—ABCC1—lymph node—thyroid cancer	0.000473	0.00666	CbGeAlD
Lamivudine—ABCB1—trachea—thyroid cancer	0.000393	0.00554	CbGeAlD
Lamivudine—ABCG2—lymph node—thyroid cancer	0.000392	0.00552	CbGeAlD
Lamivudine—Thrombocytopenia—Sorafenib—thyroid cancer	0.000384	0.00229	CcSEcCtD
Lamivudine—Aplastic anaemia—Epirubicin—thyroid cancer	0.000381	0.00227	CcSEcCtD
Lamivudine—Neuropathy—Epirubicin—thyroid cancer	0.000381	0.00227	CcSEcCtD
Lamivudine—Skin disorder—Sorafenib—thyroid cancer	0.000381	0.00227	CcSEcCtD
Lamivudine—Musculoskeletal pain—Doxorubicin—thyroid cancer	0.00038	0.00226	CcSEcCtD
Lamivudine—Anorexia—Sorafenib—thyroid cancer	0.000373	0.00223	CcSEcCtD
Lamivudine—Vomiting—Vandetanib—thyroid cancer	0.000369	0.0022	CcSEcCtD
Lamivudine—Eructation—Doxorubicin—thyroid cancer	0.000369	0.0022	CcSEcCtD
Lamivudine—Mouth ulceration—Epirubicin—thyroid cancer	0.000367	0.00219	CcSEcCtD
Lamivudine—Rash—Vandetanib—thyroid cancer	0.000366	0.00218	CcSEcCtD
Lamivudine—Dermatitis—Vandetanib—thyroid cancer	0.000366	0.00218	CcSEcCtD
Lamivudine—Headache—Vandetanib—thyroid cancer	0.000364	0.00217	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000357	0.00213	CcSEcCtD
Lamivudine—Neuropathy—Doxorubicin—thyroid cancer	0.000353	0.0021	CcSEcCtD
Lamivudine—Aplastic anaemia—Doxorubicin—thyroid cancer	0.000353	0.0021	CcSEcCtD
Lamivudine—Sepsis—Epirubicin—thyroid cancer	0.000352	0.0021	CcSEcCtD
Lamivudine—Dyspnoea—Sorafenib—thyroid cancer	0.000349	0.00208	CcSEcCtD
Lamivudine—Lymphadenopathy—Epirubicin—thyroid cancer	0.000345	0.00206	CcSEcCtD
Lamivudine—Nausea—Vandetanib—thyroid cancer	0.000345	0.00206	CcSEcCtD
Lamivudine—Dyspepsia—Sorafenib—thyroid cancer	0.000345	0.00205	CcSEcCtD
Lamivudine—Phlebitis—Epirubicin—thyroid cancer	0.000342	0.00204	CcSEcCtD
Lamivudine—Decreased appetite—Sorafenib—thyroid cancer	0.000341	0.00203	CcSEcCtD
Lamivudine—Mouth ulceration—Doxorubicin—thyroid cancer	0.000339	0.00202	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000338	0.00202	CcSEcCtD
Lamivudine—Fatigue—Sorafenib—thyroid cancer	0.000338	0.00201	CcSEcCtD
Lamivudine—Pain—Sorafenib—thyroid cancer	0.000335	0.002	CcSEcCtD
Lamivudine—Constipation—Sorafenib—thyroid cancer	0.000335	0.002	CcSEcCtD
Lamivudine—Sepsis—Doxorubicin—thyroid cancer	0.000326	0.00194	CcSEcCtD
Lamivudine—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00032	0.00191	CcSEcCtD
Lamivudine—Lymphadenopathy—Doxorubicin—thyroid cancer	0.000319	0.0019	CcSEcCtD
Lamivudine—Phlebitis—Doxorubicin—thyroid cancer	0.000316	0.00189	CcSEcCtD
Lamivudine—Urticaria—Sorafenib—thyroid cancer	0.000311	0.00185	CcSEcCtD
Lamivudine—ABCB1—thyroid gland—thyroid cancer	0.000311	0.00438	CbGeAlD
Lamivudine—Abdominal pain—Sorafenib—thyroid cancer	0.00031	0.00185	CcSEcCtD
Lamivudine—Body temperature increased—Sorafenib—thyroid cancer	0.00031	0.00185	CcSEcCtD
Lamivudine—Renal impairment—Epirubicin—thyroid cancer	0.00031	0.00184	CcSEcCtD
Lamivudine—Hypoglycaemia—Epirubicin—thyroid cancer	0.000302	0.0018	CcSEcCtD
Lamivudine—Migraine—Epirubicin—thyroid cancer	0.00029	0.00173	CcSEcCtD
Lamivudine—Affect lability—Epirubicin—thyroid cancer	0.00029	0.00173	CcSEcCtD
Lamivudine—Hypersensitivity—Sorafenib—thyroid cancer	0.000289	0.00172	CcSEcCtD
Lamivudine—Renal impairment—Doxorubicin—thyroid cancer	0.000286	0.00171	CcSEcCtD
Lamivudine—Asthenia—Sorafenib—thyroid cancer	0.000281	0.00167	CcSEcCtD
Lamivudine—Hypoglycaemia—Doxorubicin—thyroid cancer	0.000279	0.00166	CcSEcCtD
Lamivudine—Mood swings—Epirubicin—thyroid cancer	0.000279	0.00166	CcSEcCtD
Lamivudine—Pruritus—Sorafenib—thyroid cancer	0.000277	0.00165	CcSEcCtD
Lamivudine—ABCB1—head—thyroid cancer	0.000276	0.00388	CbGeAlD
Lamivudine—Dehydration—Epirubicin—thyroid cancer	0.000274	0.00163	CcSEcCtD
Lamivudine—Liver function test abnormal—Epirubicin—thyroid cancer	0.000272	0.00162	CcSEcCtD
Lamivudine—Abdominal pain upper—Epirubicin—thyroid cancer	0.000269	0.0016	CcSEcCtD
Lamivudine—Affect lability—Doxorubicin—thyroid cancer	0.000268	0.0016	CcSEcCtD
Lamivudine—Migraine—Doxorubicin—thyroid cancer	0.000268	0.0016	CcSEcCtD
Lamivudine—Diarrhoea—Sorafenib—thyroid cancer	0.000268	0.0016	CcSEcCtD
Lamivudine—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.000265	0.00158	CcSEcCtD
Lamivudine—Nasopharyngitis—Epirubicin—thyroid cancer	0.000263	0.00157	CcSEcCtD
Lamivudine—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.00026	0.00155	CcSEcCtD
Lamivudine—Muscular weakness—Epirubicin—thyroid cancer	0.00026	0.00155	CcSEcCtD
Lamivudine—Dizziness—Sorafenib—thyroid cancer	0.000259	0.00154	CcSEcCtD
Lamivudine—Mood swings—Doxorubicin—thyroid cancer	0.000258	0.00154	CcSEcCtD
Lamivudine—Abdominal distension—Epirubicin—thyroid cancer	0.000256	0.00153	CcSEcCtD
Lamivudine—Dysphagia—Epirubicin—thyroid cancer	0.000255	0.00152	CcSEcCtD
Lamivudine—Influenza—Epirubicin—thyroid cancer	0.000255	0.00152	CcSEcCtD
Lamivudine—Dehydration—Doxorubicin—thyroid cancer	0.000253	0.00151	CcSEcCtD
Lamivudine—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000252	0.0015	CcSEcCtD
Lamivudine—Pancreatitis—Epirubicin—thyroid cancer	0.00025	0.00149	CcSEcCtD
Lamivudine—Vomiting—Sorafenib—thyroid cancer	0.000249	0.00148	CcSEcCtD
Lamivudine—Abdominal pain upper—Doxorubicin—thyroid cancer	0.000249	0.00148	CcSEcCtD
Lamivudine—Rash—Sorafenib—thyroid cancer	0.000247	0.00147	CcSEcCtD
Lamivudine—Dermatitis—Sorafenib—thyroid cancer	0.000247	0.00147	CcSEcCtD
Lamivudine—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000245	0.00146	CcSEcCtD
Lamivudine—Headache—Sorafenib—thyroid cancer	0.000245	0.00146	CcSEcCtD
Lamivudine—Bronchitis—Epirubicin—thyroid cancer	0.000245	0.00146	CcSEcCtD
Lamivudine—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000244	0.00145	CcSEcCtD
Lamivudine—DCK—Doxorubicin—Epirubicin—thyroid cancer	0.000243	0.0363	CbGdCrCtD
Lamivudine—Pancytopenia—Epirubicin—thyroid cancer	0.000242	0.00144	CcSEcCtD
Lamivudine—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.00024	0.00143	CcSEcCtD
Lamivudine—Muscular weakness—Doxorubicin—thyroid cancer	0.00024	0.00143	CcSEcCtD
Lamivudine—Dysuria—Epirubicin—thyroid cancer	0.000238	0.00142	CcSEcCtD
Lamivudine—Neutropenia—Epirubicin—thyroid cancer	0.000238	0.00142	CcSEcCtD
Lamivudine—Abdominal distension—Doxorubicin—thyroid cancer	0.000237	0.00141	CcSEcCtD
Lamivudine—Influenza—Doxorubicin—thyroid cancer	0.000236	0.0014	CcSEcCtD
Lamivudine—Dysphagia—Doxorubicin—thyroid cancer	0.000236	0.0014	CcSEcCtD
Lamivudine—Pollakiuria—Epirubicin—thyroid cancer	0.000235	0.0014	CcSEcCtD
Lamivudine—Nausea—Sorafenib—thyroid cancer	0.000233	0.00139	CcSEcCtD
Lamivudine—Pancreatitis—Doxorubicin—thyroid cancer	0.000231	0.00138	CcSEcCtD
Lamivudine—Hyperglycaemia—Epirubicin—thyroid cancer	0.00023	0.00137	CcSEcCtD
Lamivudine—Bronchitis—Doxorubicin—thyroid cancer	0.000227	0.00135	CcSEcCtD
Lamivudine—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000225	0.00134	CcSEcCtD
Lamivudine—DCK—Epirubicin—Doxorubicin—thyroid cancer	0.000225	0.0336	CbGdCrCtD
Lamivudine—Pancytopenia—Doxorubicin—thyroid cancer	0.000224	0.00133	CcSEcCtD
Lamivudine—Renal failure—Epirubicin—thyroid cancer	0.000223	0.00133	CcSEcCtD
Lamivudine—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000223	0.00133	CcSEcCtD
Lamivudine—Stomatitis—Epirubicin—thyroid cancer	0.000221	0.00132	CcSEcCtD
Lamivudine—Jaundice—Epirubicin—thyroid cancer	0.000221	0.00132	CcSEcCtD
Lamivudine—Neutropenia—Doxorubicin—thyroid cancer	0.00022	0.00131	CcSEcCtD
Lamivudine—Dysuria—Doxorubicin—thyroid cancer	0.00022	0.00131	CcSEcCtD
Lamivudine—Sweating—Epirubicin—thyroid cancer	0.000218	0.0013	CcSEcCtD
Lamivudine—Pollakiuria—Doxorubicin—thyroid cancer	0.000218	0.0013	CcSEcCtD
Lamivudine—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000215	0.00128	CcSEcCtD
Lamivudine—Epistaxis—Epirubicin—thyroid cancer	0.000214	0.00128	CcSEcCtD
Lamivudine—Sinusitis—Epirubicin—thyroid cancer	0.000213	0.00127	CcSEcCtD
Lamivudine—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000212	0.00127	CcSEcCtD
Lamivudine—Agranulocytosis—Epirubicin—thyroid cancer	0.000212	0.00126	CcSEcCtD
Lamivudine—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000208	0.00124	CcSEcCtD
Lamivudine—Renal failure—Doxorubicin—thyroid cancer	0.000206	0.00123	CcSEcCtD
Lamivudine—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000206	0.00123	CcSEcCtD
Lamivudine—Stomatitis—Doxorubicin—thyroid cancer	0.000205	0.00122	CcSEcCtD
Lamivudine—Jaundice—Doxorubicin—thyroid cancer	0.000205	0.00122	CcSEcCtD
Lamivudine—Rhinitis—Epirubicin—thyroid cancer	0.000204	0.00122	CcSEcCtD
Lamivudine—Hepatitis—Epirubicin—thyroid cancer	0.000204	0.00121	CcSEcCtD
Lamivudine—Hypoaesthesia—Epirubicin—thyroid cancer	0.000203	0.00121	CcSEcCtD
Lamivudine—Pharyngitis—Epirubicin—thyroid cancer	0.000202	0.00121	CcSEcCtD
Lamivudine—Sweating—Doxorubicin—thyroid cancer	0.000201	0.0012	CcSEcCtD
Lamivudine—Connective tissue disorder—Epirubicin—thyroid cancer	0.0002	0.00119	CcSEcCtD
Lamivudine—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000199	0.00118	CcSEcCtD
Lamivudine—Epistaxis—Doxorubicin—thyroid cancer	0.000198	0.00118	CcSEcCtD
Lamivudine—Sinusitis—Doxorubicin—thyroid cancer	0.000197	0.00117	CcSEcCtD
Lamivudine—Agranulocytosis—Doxorubicin—thyroid cancer	0.000196	0.00117	CcSEcCtD
Lamivudine—ABCB1—lymph node—thyroid cancer	0.000193	0.00272	CbGeAlD
Lamivudine—Erythema multiforme—Epirubicin—thyroid cancer	0.000193	0.00115	CcSEcCtD
Lamivudine—Rhinitis—Doxorubicin—thyroid cancer	0.000189	0.00113	CcSEcCtD
Lamivudine—Hepatitis—Doxorubicin—thyroid cancer	0.000189	0.00112	CcSEcCtD
Lamivudine—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000188	0.00112	CcSEcCtD
Lamivudine—Pharyngitis—Doxorubicin—thyroid cancer	0.000187	0.00112	CcSEcCtD
Lamivudine—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000185	0.0011	CcSEcCtD
Lamivudine—Immune system disorder—Epirubicin—thyroid cancer	0.000184	0.0011	CcSEcCtD
Lamivudine—Mediastinal disorder—Epirubicin—thyroid cancer	0.000184	0.00109	CcSEcCtD
Lamivudine—Chills—Epirubicin—thyroid cancer	0.000183	0.00109	CcSEcCtD
Lamivudine—Alopecia—Epirubicin—thyroid cancer	0.00018	0.00107	CcSEcCtD
Lamivudine—Erythema multiforme—Doxorubicin—thyroid cancer	0.000178	0.00106	CcSEcCtD
Lamivudine—Malnutrition—Epirubicin—thyroid cancer	0.000177	0.00106	CcSEcCtD
Lamivudine—Erythema—Epirubicin—thyroid cancer	0.000177	0.00106	CcSEcCtD
Lamivudine—Flatulence—Epirubicin—thyroid cancer	0.000175	0.00104	CcSEcCtD
Lamivudine—Tension—Epirubicin—thyroid cancer	0.000174	0.00104	CcSEcCtD
Lamivudine—Dysgeusia—Epirubicin—thyroid cancer	0.000174	0.00104	CcSEcCtD
Lamivudine—Nervousness—Epirubicin—thyroid cancer	0.000172	0.00103	CcSEcCtD
Lamivudine—Back pain—Epirubicin—thyroid cancer	0.000172	0.00102	CcSEcCtD
Lamivudine—Muscle spasms—Epirubicin—thyroid cancer	0.000171	0.00102	CcSEcCtD
Lamivudine—Immune system disorder—Doxorubicin—thyroid cancer	0.00017	0.00101	CcSEcCtD
Lamivudine—Mediastinal disorder—Doxorubicin—thyroid cancer	0.00017	0.00101	CcSEcCtD
Lamivudine—Chills—Doxorubicin—thyroid cancer	0.000169	0.00101	CcSEcCtD
Lamivudine—Alopecia—Doxorubicin—thyroid cancer	0.000167	0.000993	CcSEcCtD
Lamivudine—Ill-defined disorder—Epirubicin—thyroid cancer	0.000165	0.000981	CcSEcCtD
Lamivudine—Erythema—Doxorubicin—thyroid cancer	0.000164	0.000978	CcSEcCtD
Lamivudine—Malnutrition—Doxorubicin—thyroid cancer	0.000164	0.000978	CcSEcCtD
Lamivudine—Anaemia—Epirubicin—thyroid cancer	0.000164	0.000977	CcSEcCtD
Lamivudine—Flatulence—Doxorubicin—thyroid cancer	0.000162	0.000964	CcSEcCtD
Lamivudine—Tension—Doxorubicin—thyroid cancer	0.000161	0.00096	CcSEcCtD
Lamivudine—Dysgeusia—Doxorubicin—thyroid cancer	0.000161	0.000958	CcSEcCtD
Lamivudine—Malaise—Epirubicin—thyroid cancer	0.00016	0.000953	CcSEcCtD
Lamivudine—Nervousness—Doxorubicin—thyroid cancer	0.000159	0.00095	CcSEcCtD
Lamivudine—Vertigo—Epirubicin—thyroid cancer	0.000159	0.00095	CcSEcCtD
Lamivudine—Syncope—Epirubicin—thyroid cancer	0.000159	0.000948	CcSEcCtD
Lamivudine—Leukopenia—Epirubicin—thyroid cancer	0.000159	0.000946	CcSEcCtD
Lamivudine—Back pain—Doxorubicin—thyroid cancer	0.000159	0.000946	CcSEcCtD
Lamivudine—Muscle spasms—Doxorubicin—thyroid cancer	0.000158	0.00094	CcSEcCtD
Lamivudine—Loss of consciousness—Epirubicin—thyroid cancer	0.000156	0.000929	CcSEcCtD
Lamivudine—Cough—Epirubicin—thyroid cancer	0.000155	0.000922	CcSEcCtD
Lamivudine—Convulsion—Epirubicin—thyroid cancer	0.000154	0.000916	CcSEcCtD
Lamivudine—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000152	0.000908	CcSEcCtD
Lamivudine—Anaemia—Doxorubicin—thyroid cancer	0.000152	0.000904	CcSEcCtD
Lamivudine—Chest pain—Epirubicin—thyroid cancer	0.000151	0.0009	CcSEcCtD
Lamivudine—Myalgia—Epirubicin—thyroid cancer	0.000151	0.0009	CcSEcCtD
Lamivudine—Arthralgia—Epirubicin—thyroid cancer	0.000151	0.0009	CcSEcCtD
Lamivudine—Anxiety—Epirubicin—thyroid cancer	0.000151	0.000897	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.00015	0.000894	CcSEcCtD
Lamivudine—Discomfort—Epirubicin—thyroid cancer	0.000149	0.000889	CcSEcCtD
Lamivudine—Malaise—Doxorubicin—thyroid cancer	0.000148	0.000882	CcSEcCtD
Lamivudine—Dry mouth—Epirubicin—thyroid cancer	0.000148	0.00088	CcSEcCtD
Lamivudine—Vertigo—Doxorubicin—thyroid cancer	0.000147	0.000879	CcSEcCtD
Lamivudine—Syncope—Doxorubicin—thyroid cancer	0.000147	0.000877	CcSEcCtD
Lamivudine—Leukopenia—Doxorubicin—thyroid cancer	0.000147	0.000876	CcSEcCtD
Lamivudine—Confusional state—Epirubicin—thyroid cancer	0.000146	0.00087	CcSEcCtD
Lamivudine—Oedema—Epirubicin—thyroid cancer	0.000145	0.000863	CcSEcCtD
Lamivudine—Anaphylactic shock—Epirubicin—thyroid cancer	0.000145	0.000863	CcSEcCtD
Lamivudine—Loss of consciousness—Doxorubicin—thyroid cancer	0.000144	0.00086	CcSEcCtD
Lamivudine—Infection—Epirubicin—thyroid cancer	0.000144	0.000857	CcSEcCtD
Lamivudine—Cough—Doxorubicin—thyroid cancer	0.000143	0.000854	CcSEcCtD
Lamivudine—Shock—Epirubicin—thyroid cancer	0.000142	0.000849	CcSEcCtD
Lamivudine—Convulsion—Doxorubicin—thyroid cancer	0.000142	0.000847	CcSEcCtD
Lamivudine—Nervous system disorder—Epirubicin—thyroid cancer	0.000142	0.000846	CcSEcCtD
Lamivudine—Thrombocytopenia—Epirubicin—thyroid cancer	0.000142	0.000845	CcSEcCtD
Lamivudine—Skin disorder—Epirubicin—thyroid cancer	0.000141	0.000838	CcSEcCtD
Lamivudine—Hyperhidrosis—Epirubicin—thyroid cancer	0.00014	0.000834	CcSEcCtD
Lamivudine—Chest pain—Doxorubicin—thyroid cancer	0.00014	0.000833	CcSEcCtD
Lamivudine—Arthralgia—Doxorubicin—thyroid cancer	0.00014	0.000833	CcSEcCtD
Lamivudine—Myalgia—Doxorubicin—thyroid cancer	0.00014	0.000833	CcSEcCtD
Lamivudine—Anxiety—Doxorubicin—thyroid cancer	0.000139	0.00083	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000139	0.000827	CcSEcCtD
Lamivudine—Discomfort—Doxorubicin—thyroid cancer	0.000138	0.000823	CcSEcCtD
Lamivudine—Anorexia—Epirubicin—thyroid cancer	0.000138	0.000822	CcSEcCtD
Lamivudine—Dry mouth—Doxorubicin—thyroid cancer	0.000137	0.000814	CcSEcCtD
Lamivudine—Hypotension—Epirubicin—thyroid cancer	0.000135	0.000806	CcSEcCtD
Lamivudine—Confusional state—Doxorubicin—thyroid cancer	0.000135	0.000805	CcSEcCtD
Lamivudine—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000134	0.000798	CcSEcCtD
Lamivudine—Oedema—Doxorubicin—thyroid cancer	0.000134	0.000798	CcSEcCtD
Lamivudine—Infection—Doxorubicin—thyroid cancer	0.000133	0.000793	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000132	0.000786	CcSEcCtD
Lamivudine—Shock—Doxorubicin—thyroid cancer	0.000132	0.000785	CcSEcCtD
Lamivudine—Nervous system disorder—Doxorubicin—thyroid cancer	0.000131	0.000783	CcSEcCtD
Lamivudine—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000131	0.000782	CcSEcCtD
Lamivudine—Insomnia—Epirubicin—thyroid cancer	0.000131	0.00078	CcSEcCtD
Lamivudine—Skin disorder—Doxorubicin—thyroid cancer	0.00013	0.000775	CcSEcCtD
Lamivudine—SLC22A1—SLC-mediated transmembrane transport—CP—thyroid cancer	0.00013	0.00159	CbGpPWpGaD
Lamivudine—SLC22A1—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.00013	0.00159	CbGpPWpGaD
Lamivudine—Paraesthesia—Epirubicin—thyroid cancer	0.00013	0.000775	CcSEcCtD
Lamivudine—Hyperhidrosis—Doxorubicin—thyroid cancer	0.00013	0.000772	CcSEcCtD
Lamivudine—Dyspnoea—Epirubicin—thyroid cancer	0.000129	0.000769	CcSEcCtD
Lamivudine—Somnolence—Epirubicin—thyroid cancer	0.000129	0.000767	CcSEcCtD
Lamivudine—Anorexia—Doxorubicin—thyroid cancer	0.000128	0.000761	CcSEcCtD
Lamivudine—Dyspepsia—Epirubicin—thyroid cancer	0.000127	0.000759	CcSEcCtD
Lamivudine—Decreased appetite—Epirubicin—thyroid cancer	0.000126	0.00075	CcSEcCtD
Lamivudine—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000125	0.00154	CbGpPWpGaD
Lamivudine—Hypotension—Doxorubicin—thyroid cancer	0.000125	0.000746	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000125	0.000745	CcSEcCtD
Lamivudine—Fatigue—Epirubicin—thyroid cancer	0.000125	0.000744	CcSEcCtD
Lamivudine—Constipation—Epirubicin—thyroid cancer	0.000124	0.000738	CcSEcCtD
Lamivudine—Pain—Epirubicin—thyroid cancer	0.000124	0.000738	CcSEcCtD
Lamivudine—PCYT1A—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	0.000124	0.00152	CbGpPWpGaD
Lamivudine—PGK1—Disease—NRG1—thyroid cancer	0.000123	0.00151	CbGpPWpGaD
Lamivudine—NME1—Metabolism—TPR—thyroid cancer	0.000122	0.0015	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	0.000122	0.0015	CbGpPWpGaD
Lamivudine—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000122	0.000727	CcSEcCtD
Lamivudine—SLC22A3—Metabolism—NDUFA13—thyroid cancer	0.000122	0.00149	CbGpPWpGaD
Lamivudine—Insomnia—Doxorubicin—thyroid cancer	0.000121	0.000722	CcSEcCtD
Lamivudine—NME2—Metabolism—SLC5A5—thyroid cancer	0.000121	0.00148	CbGpPWpGaD
Lamivudine—Paraesthesia—Doxorubicin—thyroid cancer	0.00012	0.000717	CcSEcCtD
Lamivudine—NME1—Metabolism—PRKAR1A—thyroid cancer	0.00012	0.00147	CbGpPWpGaD
Lamivudine—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—thyroid cancer	0.00012	0.00147	CbGpPWpGaD
Lamivudine—Dyspnoea—Doxorubicin—thyroid cancer	0.000119	0.000712	CcSEcCtD
Lamivudine—PGK1—Metabolism—RXRA—thyroid cancer	0.000119	0.00146	CbGpPWpGaD
Lamivudine—Feeling abnormal—Epirubicin—thyroid cancer	0.000119	0.000711	CcSEcCtD
Lamivudine—Somnolence—Doxorubicin—thyroid cancer	0.000119	0.00071	CcSEcCtD
Lamivudine—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000118	0.000705	CcSEcCtD
Lamivudine—Dyspepsia—Doxorubicin—thyroid cancer	0.000118	0.000703	CcSEcCtD
Lamivudine—Decreased appetite—Doxorubicin—thyroid cancer	0.000116	0.000694	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000116	0.000689	CcSEcCtD
Lamivudine—Fatigue—Doxorubicin—thyroid cancer	0.000115	0.000688	CcSEcCtD
Lamivudine—Urticaria—Epirubicin—thyroid cancer	0.000115	0.000685	CcSEcCtD
Lamivudine—Pain—Doxorubicin—thyroid cancer	0.000115	0.000683	CcSEcCtD
Lamivudine—Constipation—Doxorubicin—thyroid cancer	0.000115	0.000683	CcSEcCtD
Lamivudine—Body temperature increased—Epirubicin—thyroid cancer	0.000114	0.000682	CcSEcCtD
Lamivudine—Abdominal pain—Epirubicin—thyroid cancer	0.000114	0.000682	CcSEcCtD
Lamivudine—SLC22A3—Metabolism—CHST14—thyroid cancer	0.000114	0.0014	CbGpPWpGaD
Lamivudine—SLC22A3—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000113	0.00139	CbGpPWpGaD
Lamivudine—SLC22A3—Transmembrane transport of small molecules—CP—thyroid cancer	0.000113	0.00139	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—NDUFA13—thyroid cancer	0.000112	0.00137	CbGpPWpGaD
Lamivudine—ABCB1—HIF-1-alpha transcription factor network—TERT—thyroid cancer	0.000111	0.00137	CbGpPWpGaD
Lamivudine—SLC22A3—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000111	0.00136	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—PRKAR1A—thyroid cancer	0.000111	0.00136	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—RXRA—thyroid cancer	0.000111	0.00136	CbGpPWpGaD
Lamivudine—PGK1—Disease—TERT—thyroid cancer	0.000111	0.00136	CbGpPWpGaD
Lamivudine—Feeling abnormal—Doxorubicin—thyroid cancer	0.00011	0.000658	CcSEcCtD
Lamivudine—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.00011	0.000653	CcSEcCtD
Lamivudine—PCYT1A—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	0.000108	0.00132	CbGpPWpGaD
Lamivudine—Hypersensitivity—Epirubicin—thyroid cancer	0.000107	0.000636	CcSEcCtD
Lamivudine—ABCB1—HIF-1-alpha transcription factor network—HIF1A—thyroid cancer	0.000107	0.00131	CbGpPWpGaD
Lamivudine—Urticaria—Doxorubicin—thyroid cancer	0.000106	0.000634	CcSEcCtD
Lamivudine—Body temperature increased—Doxorubicin—thyroid cancer	0.000106	0.000631	CcSEcCtD
Lamivudine—Abdominal pain—Doxorubicin—thyroid cancer	0.000106	0.000631	CcSEcCtD
Lamivudine—PGK1—Disease—HIF1A—thyroid cancer	0.000106	0.0013	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—CHST14—thyroid cancer	0.000105	0.00129	CbGpPWpGaD
Lamivudine—ABCC1—Disease—TRIM24—thyroid cancer	0.000105	0.00128	CbGpPWpGaD
Lamivudine—SLC22A2—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000104	0.00128	CbGpPWpGaD
Lamivudine—ABCC3—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000104	0.00127	CbGpPWpGaD
Lamivudine—ABCC3—Transmembrane transport of small molecules—CP—thyroid cancer	0.000104	0.00127	CbGpPWpGaD
Lamivudine—Asthenia—Epirubicin—thyroid cancer	0.000104	0.000619	CcSEcCtD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	0.000103	0.00127	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—MINPP1—thyroid cancer	0.000103	0.00126	CbGpPWpGaD
Lamivudine—Pruritus—Epirubicin—thyroid cancer	0.000102	0.00061	CcSEcCtD
Lamivudine—ABCC3—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000102	0.00125	CbGpPWpGaD
Lamivudine—NME2—Metabolism—RXRA—thyroid cancer	0.000101	0.00124	CbGpPWpGaD
Lamivudine—Diarrhoea—Epirubicin—thyroid cancer	9.91e-05	0.00059	CcSEcCtD
Lamivudine—Hypersensitivity—Doxorubicin—thyroid cancer	9.87e-05	0.000588	CcSEcCtD
Lamivudine—ABCC1—Disease—CHST14—thyroid cancer	9.84e-05	0.00121	CbGpPWpGaD
Lamivudine—ABCC4—Transmembrane transport of small molecules—CP—thyroid cancer	9.77e-05	0.0012	CbGpPWpGaD
Lamivudine—ABCC4—Transmembrane transport of small molecules—TPR—thyroid cancer	9.77e-05	0.0012	CbGpPWpGaD
Lamivudine—SLC22A1—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	9.74e-05	0.00119	CbGpPWpGaD
Lamivudine—ABCC4—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	9.61e-05	0.00118	CbGpPWpGaD
Lamivudine—Asthenia—Doxorubicin—thyroid cancer	9.61e-05	0.000573	CcSEcCtD
Lamivudine—Dizziness—Epirubicin—thyroid cancer	9.57e-05	0.000571	CcSEcCtD
Lamivudine—Pruritus—Doxorubicin—thyroid cancer	9.48e-05	0.000565	CcSEcCtD
Lamivudine—ABCC1—Disease—TRIM33—thyroid cancer	9.33e-05	0.00114	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—PPARG—thyroid cancer	9.24e-05	0.00113	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—PPARG—thyroid cancer	9.24e-05	0.00113	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—PPARG—thyroid cancer	9.24e-05	0.00113	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—HPGD—thyroid cancer	9.22e-05	0.00113	CbGpPWpGaD
Lamivudine—Vomiting—Epirubicin—thyroid cancer	9.21e-05	0.000549	CcSEcCtD
Lamivudine—Diarrhoea—Doxorubicin—thyroid cancer	9.17e-05	0.000546	CcSEcCtD
Lamivudine—NME1—Metabolism—SLC5A5—thyroid cancer	9.15e-05	0.00112	CbGpPWpGaD
Lamivudine—Rash—Epirubicin—thyroid cancer	9.13e-05	0.000544	CcSEcCtD
Lamivudine—Dermatitis—Epirubicin—thyroid cancer	9.12e-05	0.000543	CcSEcCtD
Lamivudine—Headache—Epirubicin—thyroid cancer	9.07e-05	0.00054	CcSEcCtD
Lamivudine—ABCG2—Metabolism—MINPP1—thyroid cancer	9.07e-05	0.00111	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—MINPP1—thyroid cancer	8.97e-05	0.0011	CbGpPWpGaD
Lamivudine—Dizziness—Doxorubicin—thyroid cancer	8.86e-05	0.000528	CcSEcCtD
Lamivudine—PGK1—Disease—BRAF—thyroid cancer	8.76e-05	0.00107	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—NDUFA13—thyroid cancer	8.76e-05	0.00107	CbGpPWpGaD
Lamivudine—Nausea—Epirubicin—thyroid cancer	8.6e-05	0.000512	CcSEcCtD
Lamivudine—Vomiting—Doxorubicin—thyroid cancer	8.52e-05	0.000508	CcSEcCtD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—TPR—thyroid cancer	8.51e-05	0.00104	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—CP—thyroid cancer	8.51e-05	0.00104	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—HPGD—thyroid cancer	8.47e-05	0.00104	CbGpPWpGaD
Lamivudine—SLC22A3—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	8.46e-05	0.00104	CbGpPWpGaD
Lamivudine—Rash—Doxorubicin—thyroid cancer	8.45e-05	0.000503	CcSEcCtD
Lamivudine—Dermatitis—Doxorubicin—thyroid cancer	8.44e-05	0.000503	CcSEcCtD
Lamivudine—Headache—Doxorubicin—thyroid cancer	8.39e-05	0.0005	CcSEcCtD
Lamivudine—DCK—Metabolism—TPR—thyroid cancer	8.39e-05	0.00103	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	8.37e-05	0.00103	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—MINPP1—thyroid cancer	8.36e-05	0.00103	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PRKAR1A—thyroid cancer	8.25e-05	0.00101	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—TPR—thyroid cancer	8.24e-05	0.00101	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—CP—thyroid cancer	8.24e-05	0.00101	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CHST14—thyroid cancer	8.24e-05	0.00101	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—TPR—thyroid cancer	8.14e-05	0.000998	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—CP—thyroid cancer	8.14e-05	0.000998	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	8.11e-05	0.000994	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	8.01e-05	0.000982	CbGpPWpGaD
Lamivudine—Nausea—Doxorubicin—thyroid cancer	7.96e-05	0.000474	CcSEcCtD
Lamivudine—ABCC3—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	7.78e-05	0.000954	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—NDUFA13—thyroid cancer	7.71e-05	0.000945	CbGpPWpGaD
Lamivudine—NME1—Metabolism—RXRA—thyroid cancer	7.69e-05	0.000943	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—NDUFA13—thyroid cancer	7.63e-05	0.000936	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—PPARG—thyroid cancer	7.53e-05	0.000924	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—IFNA2—thyroid cancer	7.36e-05	0.000902	CbGpPWpGaD
Lamivudine—ABCC4—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	7.31e-05	0.000897	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—PTGS2—thyroid cancer	7.27e-05	0.000891	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—PTGS2—thyroid cancer	7.27e-05	0.000891	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—PTGS2—thyroid cancer	7.27e-05	0.000891	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CHST14—thyroid cancer	7.25e-05	0.000889	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CHST14—thyroid cancer	7.17e-05	0.00088	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—TPR—thyroid cancer	7.17e-05	0.000878	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—CP—thyroid cancer	7.17e-05	0.000878	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—NDUFA13—thyroid cancer	7.11e-05	0.000872	CbGpPWpGaD
Lamivudine—SLC22A3—Transmembrane transport of small molecules—RXRA—thyroid cancer	7.11e-05	0.000872	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—CP—thyroid cancer	7.09e-05	0.000869	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—TPR—thyroid cancer	7.09e-05	0.000869	CbGpPWpGaD
Lamivudine—PGK1—Disease—PTGS2—thyroid cancer	7.08e-05	0.000868	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	7.05e-05	0.000864	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—PPARG—thyroid cancer	7e-05	0.000859	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	6.98e-05	0.000855	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	6.87e-05	0.000843	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CHST14—thyroid cancer	6.69e-05	0.00082	CbGpPWpGaD
Lamivudine—SLC22A2—Transmission across Chemical Synapses—BRAF—thyroid cancer	6.66e-05	0.000816	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—HPGD—thyroid cancer	6.64e-05	0.000814	CbGpPWpGaD
Lamivudine—ABCG2—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	6.63e-05	0.000813	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—TPR—thyroid cancer	6.61e-05	0.00081	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—CP—thyroid cancer	6.61e-05	0.00081	CbGpPWpGaD
Lamivudine—ABCC3—Transmembrane transport of small molecules—RXRA—thyroid cancer	6.54e-05	0.000801	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	6.5e-05	0.000797	CbGpPWpGaD
Lamivudine—NME2—Metabolism—PPARG—thyroid cancer	6.41e-05	0.000785	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	6.37e-05	0.000781	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—PTEN—thyroid cancer	6.34e-05	0.000777	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—PTEN—thyroid cancer	6.34e-05	0.000777	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—PTEN—thyroid cancer	6.34e-05	0.000777	CbGpPWpGaD
Lamivudine—DCK—Metabolism—SLC5A5—thyroid cancer	6.28e-05	0.00077	CbGpPWpGaD
Lamivudine—ABCC1—Disease—TCF7L1—thyroid cancer	6.22e-05	0.000763	CbGpPWpGaD
Lamivudine—SLC22A1—Transmission across Chemical Synapses—BRAF—thyroid cancer	6.21e-05	0.000761	CbGpPWpGaD
Lamivudine—PGK1—Disease—PTEN—thyroid cancer	6.17e-05	0.000757	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	6.17e-05	0.000756	CbGpPWpGaD
Lamivudine—ABCC4—Transmembrane transport of small molecules—RXRA—thyroid cancer	6.15e-05	0.000753	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	6.14e-05	0.000752	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	6.1e-05	0.000747	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—PTGS2—thyroid cancer	5.93e-05	0.000727	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—HPGD—thyroid cancer	5.84e-05	0.000716	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—HPGD—thyroid cancer	5.78e-05	0.000709	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—PTGS2—thyroid cancer	5.51e-05	0.000676	CbGpPWpGaD
Lamivudine—PGK1—Disease—NRAS—thyroid cancer	5.51e-05	0.000675	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—HPGD—thyroid cancer	5.39e-05	0.000661	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	5.39e-05	0.00066	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	5.36e-05	0.000658	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—RXRA—thyroid cancer	5.35e-05	0.000656	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	5.31e-05	0.000651	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—TPR—thyroid cancer	5.3e-05	0.000649	CbGpPWpGaD
Lamivudine—DCK—Metabolism—RXRA—thyroid cancer	5.27e-05	0.000647	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PRKAR1A—thyroid cancer	5.21e-05	0.000639	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—RXRA—thyroid cancer	5.18e-05	0.000635	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—PTEN—thyroid cancer	5.17e-05	0.000634	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—RXRA—thyroid cancer	5.12e-05	0.000628	CbGpPWpGaD
Lamivudine—SLC22A2—Neuronal System—BRAF—thyroid cancer	5.1e-05	0.000625	CbGpPWpGaD
Lamivudine—NME2—Metabolism—PTGS2—thyroid cancer	5.04e-05	0.000618	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	4.95e-05	0.000607	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—MINPP1—thyroid cancer	4.9e-05	0.000601	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—TPR—thyroid cancer	4.87e-05	0.000597	CbGpPWpGaD
Lamivudine—NME1—Metabolism—PPARG—thyroid cancer	4.86e-05	0.000595	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—PTEN—thyroid cancer	4.81e-05	0.000589	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PRKAR1A—thyroid cancer	4.79e-05	0.000587	CbGpPWpGaD
Lamivudine—SLC22A1—Neuronal System—BRAF—thyroid cancer	4.75e-05	0.000583	CbGpPWpGaD
Lamivudine—PGK1—Disease—KRAS—thyroid cancer	4.74e-05	0.000581	CbGpPWpGaD
Lamivudine—ABCC1—Disease—TPR—thyroid cancer	4.55e-05	0.000558	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—RXRA—thyroid cancer	4.51e-05	0.000553	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PRKAR1A—thyroid cancer	4.48e-05	0.000549	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—RXRA—thyroid cancer	4.46e-05	0.000547	CbGpPWpGaD
Lamivudine—NME2—Metabolism—PTEN—thyroid cancer	4.4e-05	0.000539	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	4.34e-05	0.000532	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MEN1—thyroid cancer	4.28e-05	0.000525	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—NDUFA13—thyroid cancer	4.17e-05	0.000511	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—RXRA—thyroid cancer	4.16e-05	0.00051	CbGpPWpGaD
Lamivudine—PGK1—Disease—HRAS—thyroid cancer	4.03e-05	0.000494	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—SLC5A5—thyroid cancer	3.96e-05	0.000486	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CHST14—thyroid cancer	3.92e-05	0.000481	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	3.87e-05	0.000475	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	3.87e-05	0.000475	CbGpPWpGaD
Lamivudine—NME1—Metabolism—PTGS2—thyroid cancer	3.82e-05	0.000468	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—TPR—thyroid cancer	3.81e-05	0.000468	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	3.81e-05	0.000467	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PRKAR1A—thyroid cancer	3.75e-05	0.00046	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—AKT1—thyroid cancer	3.65e-05	0.000448	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—AKT1—thyroid cancer	3.65e-05	0.000448	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—AKT1—thyroid cancer	3.65e-05	0.000448	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—SLC5A5—thyroid cancer	3.64e-05	0.000447	CbGpPWpGaD
Lamivudine—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	3.58e-05	0.000439	CbGpPWpGaD
Lamivudine—PGK1—Disease—AKT1—thyroid cancer	3.56e-05	0.000436	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	3.44e-05	0.000422	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.41e-05	0.000419	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CALCA—thyroid cancer	3.41e-05	0.000418	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.4e-05	0.000417	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—TPR—thyroid cancer	3.36e-05	0.000411	CbGpPWpGaD
Lamivudine—NME1—Metabolism—PTEN—thyroid cancer	3.33e-05	0.000408	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—RXRA—thyroid cancer	3.33e-05	0.000408	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PPARG—thyroid cancer	3.33e-05	0.000408	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—TPR—thyroid cancer	3.32e-05	0.000407	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PRKAR1A—thyroid cancer	3.3e-05	0.000405	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PRKAR1A—thyroid cancer	3.27e-05	0.000401	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—HPGD—thyroid cancer	3.16e-05	0.000387	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—TPR—thyroid cancer	3.1e-05	0.00038	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CDK1—thyroid cancer	3.09e-05	0.000378	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—RXRA—thyroid cancer	3.06e-05	0.000375	CbGpPWpGaD
Lamivudine—SLC22A2—Transmission across Chemical Synapses—HRAS—thyroid cancer	3.06e-05	0.000375	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	3.05e-05	0.000374	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PRKAR1A—thyroid cancer	3.05e-05	0.000373	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—AKT1—thyroid cancer	2.98e-05	0.000365	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.98e-05	0.000365	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	2.9e-05	0.000356	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—SLC5A5—thyroid cancer	2.86e-05	0.00035	CbGpPWpGaD
Lamivudine—SLC22A1—Transmission across Chemical Synapses—HRAS—thyroid cancer	2.85e-05	0.00035	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—AKT1—thyroid cancer	2.77e-05	0.00034	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	2.75e-05	0.000338	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—NRAS—thyroid cancer	2.74e-05	0.000336	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.68e-05	0.000328	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	2.66e-05	0.000326	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PTGS2—thyroid cancer	2.62e-05	0.000321	CbGpPWpGaD
Lamivudine—NME2—Metabolism—AKT1—thyroid cancer	2.53e-05	0.000311	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—SLC5A5—thyroid cancer	2.51e-05	0.000308	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—SLC5A5—thyroid cancer	2.49e-05	0.000305	CbGpPWpGaD
Lamivudine—ABCC1—Disease—NRG1—thyroid cancer	2.48e-05	0.000304	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	2.44e-05	0.000299	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—RXRA—thyroid cancer	2.4e-05	0.000294	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—KRAS—thyroid cancer	2.36e-05	0.000289	CbGpPWpGaD
Lamivudine—SLC22A2—Neuronal System—HRAS—thyroid cancer	2.35e-05	0.000288	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.33e-05	0.000286	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—SLC5A5—thyroid cancer	2.32e-05	0.000284	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PTEN—thyroid cancer	2.28e-05	0.00028	CbGpPWpGaD
Lamivudine—ABCC1—Disease—TERT—thyroid cancer	2.22e-05	0.000273	CbGpPWpGaD
Lamivudine—SLC22A1—Neuronal System—HRAS—thyroid cancer	2.19e-05	0.000268	CbGpPWpGaD
Lamivudine—ABCC1—Disease—HIF1A—thyroid cancer	2.13e-05	0.000261	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—RXRA—thyroid cancer	2.11e-05	0.000259	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PPARG—thyroid cancer	2.1e-05	0.000258	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—TP53—thyroid cancer	2.1e-05	0.000257	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—RXRA—thyroid cancer	2.09e-05	0.000256	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	2.04e-05	0.00025	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—HRAS—thyroid cancer	2.01e-05	0.000246	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—RXRA—thyroid cancer	1.95e-05	0.000239	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PPARG—thyroid cancer	1.93e-05	0.000237	CbGpPWpGaD
Lamivudine—NME1—Metabolism—AKT1—thyroid cancer	1.92e-05	0.000235	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—TPR—thyroid cancer	1.81e-05	0.000222	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	1.81e-05	0.000222	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PRKAR1A—thyroid cancer	1.79e-05	0.000219	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—AKT1—thyroid cancer	1.77e-05	0.000217	CbGpPWpGaD
Lamivudine—ABCC1—Disease—BRAF—thyroid cancer	1.76e-05	0.000216	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PTGS2—thyroid cancer	1.65e-05	0.000203	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	1.53e-05	0.000188	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PTGS2—thyroid cancer	1.52e-05	0.000186	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PPARG—thyroid cancer	1.51e-05	0.000186	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PTEN—thyroid cancer	1.44e-05	0.000177	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PTGS2—thyroid cancer	1.42e-05	0.000174	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SLC5A5—thyroid cancer	1.36e-05	0.000167	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PPARG—thyroid cancer	1.33e-05	0.000163	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PTEN—thyroid cancer	1.33e-05	0.000163	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PPARG—thyroid cancer	1.32e-05	0.000162	CbGpPWpGaD
Lamivudine—DCK—Metabolism—AKT1—thyroid cancer	1.32e-05	0.000161	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PTEN—thyroid cancer	1.24e-05	0.000152	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PPARG—thyroid cancer	1.23e-05	0.000151	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PTGS2—thyroid cancer	1.19e-05	0.000146	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—RXRA—thyroid cancer	1.14e-05	0.00014	CbGpPWpGaD
Lamivudine—ABCC1—Disease—NRAS—thyroid cancer	1.11e-05	0.000136	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PTGS2—thyroid cancer	1.05e-05	0.000129	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PTEN—thyroid cancer	1.04e-05	0.000127	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PTGS2—thyroid cancer	1.04e-05	0.000127	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PTGS2—thyroid cancer	9.67e-06	0.000119	CbGpPWpGaD
Lamivudine—ABCC1—Disease—KRAS—thyroid cancer	9.53e-06	0.000117	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PTEN—thyroid cancer	9.14e-06	0.000112	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PTEN—thyroid cancer	9.05e-06	0.000111	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PTEN—thyroid cancer	8.43e-06	0.000103	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—AKT1—thyroid cancer	8.31e-06	0.000102	CbGpPWpGaD
Lamivudine—ABCC1—Disease—HRAS—thyroid cancer	8.1e-06	9.93e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—AKT1—thyroid cancer	7.64e-06	9.37e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PPARG—thyroid cancer	7.21e-06	8.83e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—AKT1—thyroid cancer	7.15e-06	8.77e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—AKT1—thyroid cancer	5.99e-06	7.34e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PTGS2—thyroid cancer	5.67e-06	6.95e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—AKT1—thyroid cancer	5.27e-06	6.46e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—AKT1—thyroid cancer	5.21e-06	6.39e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PTEN—thyroid cancer	4.94e-06	6.06e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—AKT1—thyroid cancer	4.86e-06	5.96e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—AKT1—thyroid cancer	2.85e-06	3.49e-05	CbGpPWpGaD
